Isra Rana

506 total citations
10 papers, 389 citations indexed

About

Isra Rana is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Isra Rana has authored 10 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmaceutical Science and 4 papers in Immunology. Recurrent topics in Isra Rana's work include Advancements in Transdermal Drug Delivery (3 papers), Immunotherapy and Immune Responses (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Isra Rana is often cited by papers focused on Advancements in Transdermal Drug Delivery (3 papers), Immunotherapy and Immune Responses (3 papers) and Nanoparticle-Based Drug Delivery (2 papers). Isra Rana collaborates with scholars based in South Korea, Pakistan and China. Isra Rana's co-authors include Jin‐Ki Kim, Alam Zeb, Namrah Khan, Fawad Ali Shah, Fakhar ud Din, Ho-Ik Choi, Cheol‐Ho Lee, Muhammad Mohsin Ansari, Jutaek Nam and Omer Salman Qureshi and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Isra Rana

9 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isra Rana South Korea	7	166	150	70	69	37	10	389
Namrah Khan South Korea	6	176 1.1×	215 1.4×	66 0.9×	44 0.6×	21 0.6×	9	444
Teng Li China	11	185 1.1×	121 0.8×	75 1.1×	67 1.0×	54 1.5×	18	480
Ho-Ik Choi South Korea	9	145 0.9×	136 0.9×	46 0.7×	45 0.7×	15 0.4×	14	346
Soraia Pinto Portugal	11	122 0.7×	164 1.1×	107 1.5×	67 1.0×	14 0.4×	19	441
Laura Bayón‐Cordero Spain	7	160 1.0×	88 0.6×	112 1.6×	63 0.9×	28 0.8×	8	396
Dnyandev Gadhave India	13	199 1.2×	285 1.9×	111 1.6×	59 0.9×	14 0.4×	25	550
Chunjie Sha China	13	132 0.8×	57 0.4×	105 1.5×	96 1.4×	22 0.6×	26	364
Hussein M. Eid Egypt	15	193 1.2×	476 3.2×	137 2.0×	35 0.5×	20 0.5×	24	744
Jing‐Shiun Jan Taiwan	8	126 0.8×	63 0.4×	61 0.9×	33 0.5×	22 0.6×	14	282
Shaimaa S. Ibrahim Egypt	10	96 0.6×	94 0.6×	64 0.9×	32 0.5×	13 0.4×	16	318

Countries citing papers authored by Isra Rana

Since Specialization

Citations

This map shows the geographic impact of Isra Rana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isra Rana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isra Rana more than expected).

Fields of papers citing papers by Isra Rana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isra Rana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isra Rana. The network helps show where Isra Rana may publish in the future.

Co-authorship network of co-authors of Isra Rana

This figure shows the co-authorship network connecting the top 25 collaborators of Isra Rana. A scholar is included among the top collaborators of Isra Rana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isra Rana. Isra Rana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rana, Isra, et al.. (2025). Nanoengineering of cyclic dinucleotide‑manganese complexes using biodegradable mesoporous silica nanoparticles for cancer metallo-immunotherapy. Journal of Controlled Release. 390. 114588–114588.

Zhang, Zhengzheng, Isra Rana, & Jutaek Nam. (2025). Metal coordination polymer nanoparticles for cancer therapy. Essays in Biochemistry. 69(2). 133–146. 2 indexed citations

Rana, Isra, et al.. (2023). Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy. Journal of Pharmaceutical Investigation. 53(5). 685–706. 6 indexed citations

Rana, Isra, et al.. (2023). Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy. ACS Applied Bio Materials. 7(8). 4944–4961. 4 indexed citations

Rana, Isra, et al.. (2022). Nanocarriers for cancer nano-immunotherapy. Drug Delivery and Translational Research. 13(7). 1936–1954. 48 indexed citations

Choi, Ho-Ik, Alam Zeb, Isra Rana, et al.. (2022). Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs). Journal of Controlled Release. 350. 652–667. 49 indexed citations

Rana, Isra, Namrah Khan, Izhar Ullah, et al.. (2021). Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. International Journal of Pharmaceutics. 603. 120670–120670. 61 indexed citations

Zeb, Alam, Isra Rana, Ho-Ik Choi, et al.. (2020). Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals. Pharmaceutics. 12(12). 1184–1184. 67 indexed citations

Rana, Isra, Namrah Khan, Muhammad Mohsin Ansari, et al.. (2020). Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids and Surfaces B Biointerfaces. 194. 111209–111209. 70 indexed citations

10.

Khan, Namrah, Fawad Ali Shah, Isra Rana, et al.. (2020). Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity. International Journal of Pharmaceutics. 577. 119033–119033. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact